Sabiia Seb
PortuguêsEspañolEnglish
Embrapa
        Busca avançada

Botão Atualizar


Botão Atualizar

Registro completo
Provedor de dados:  ArchiMer
País:  France
Título:  Is adaptive therapy natural?
Autores:  Thomas, Frederic
Donnadieu, Emmanuel
Charriere, Guillaume
Jacqueline, Camille
Tasiemski, Aurelie
Pujol, Pascal
Renaud, Francois
Roche, Benjamin
Hamede, Rodrigo
Brown, Joel
Gatenby, Robert
Ujvari, Beata
Data:  2018-10
Ano:  2018
Resumo:  Research suggests that progression-free survival can be prolonged by integrating evolutionary principles into clinical cancer treatment protocols. The goal is to prevent or slow the proliferation of resistant malignant cell populations. The logic behind this therapy relies on ecological and evolutionary processes. These same processes would be available to natural selection in decreasing the probability of an organism's death due to cancer. We propose that organisms' anticancer adaptions include not only ones for preventing cancer but also ones for directing and retarding the evolution of life-threatening cancer cells. We term this last strategy natural adaptive therapy (NAT). The body's NAT might include a lower than otherwise possible immune response. A restrained immune response might forego maximum short-term kill rates. Restraint would forestall immune-resistant cancer cells and produce long-term durable control of the cancer population. Here, we define, develop, and explore the possibility of NAT. The discovery of NAT mechanisms could identify new strategies in tumor prevention and treatments. Furthermore, we discuss the potential risks of immunotherapies that force the immune system to ramp up the short-term kill rates of malignant cancer cells in a manner that undermines the body's NAT and accelerates the evolution of immune resistance.
Tipo:  Text
Idioma:  Inglês
Identificador:  https://archimer.ifremer.fr/doc/00470/58122/60546.pdf

DOI:10.1371/journal.pbio.2007066

https://archimer.ifremer.fr/doc/00470/58122/
Editor:  Public Library Science
Formato:  application/pdf
Fonte:  Plos Biology (1545-7885) (Public Library Science), 2018-10 , Vol. 16 , N. 10 , P. e2007066 (12p.)
Direitos:  info:eu-repo/semantics/openAccess

restricted use
Fechar
 

Empresa Brasileira de Pesquisa Agropecuária - Embrapa
Todos os direitos reservados, conforme Lei n° 9.610
Política de Privacidade
Área restrita

Embrapa
Parque Estação Biológica - PqEB s/n°
Brasília, DF - Brasil - CEP 70770-901
Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco

Valid HTML 4.01 Transitional